The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The Emmes Company LLC, a for-profit limited liability company, to serve as the NIDA Data, Statistics, and Clinical Trial Support Center.
Under this single-award IDIQ contract valued up to $31.2 million over a five-year period from September 2022 to September 2027, The Emmes Company will provide data management, statistical analysis, document management, and clinical trial support services to NIDA's National Drug Abuse Treatment Clinical Trials Network. The contract aims to support NIDA's expanding portfolio of opioid treatment trials as well as other clinical studies focused on developing new therapies and improving access to evidence-based addiction treatment. Task orders issued under this IDIQ contract range from $214,000 to $2.3 million and cover a variety of clinical research activities, including data coordination, statistical analysis, patient safety monitoring, and logistical support for NIDA's substance abuse research programs.
Generated 3/22/24, 9:15 AM